An economic evaluation of the costs and benefits of heparin rationalisation in a hospital pharmacy
被引:0
作者:
Penny Reeves
论文数: 0引用数: 0
h-index: 0
机构:Fourth Hurdle Consulting Ltd,
Penny Reeves
Jonathan Cooke
论文数: 0引用数: 0
h-index: 0
机构:Fourth Hurdle Consulting Ltd,
Jonathan Cooke
Adam Lloyd
论文数: 0引用数: 0
h-index: 0
机构:Fourth Hurdle Consulting Ltd,
Adam Lloyd
Adam Hutchings
论文数: 0引用数: 0
h-index: 0
机构:Fourth Hurdle Consulting Ltd,
Adam Hutchings
机构:
[1] Fourth Hurdle Consulting Ltd,
[2] Wythenshawe Hospital,undefined
来源:
Pharmacy World and Science
|
2004年
/
26卷
关键词:
Economics;
Heparin;
Hospital pharmacy;
Pharmacy stock;
United Kingdom;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Aim: To estimate the costs and benefits for a UK hospital pharmacy of stocking a single low molecular weight heparin (LMWH), enoxaparin, compared to stocking unfractionated heparin (UFH) and stocking both UFH and multiple different LMWHs.